封面
市场调查报告书
商品编码
1417394

全球 HbA1c 测试市场:趋势、预测、竞争分析(~2030 年)

HbA1c Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

HbA1c 检测趋势与预测

预计到 2030 年,全球 HbA1c 检测市场规模将达到约 34 亿美元,2024 年至 2030 年复合年增长率为 12.5%。该市场的主要驱动因素是糖尿病盛行率的增加和血糖控制意识的提高。全球 HbA1c 检测市场的未来看起来充满希望,医院/诊所、诊断实验室、居家医疗和研究市场都充满机会。

HbA1c 测试市场洞察

Lucintel 预测,比浊免疫检测可提供准确的结果且具有成本效益,预计将在预测期内实现最高成长。

由于老年人口的增加,预计医院和诊所仍将是该市场的最大部分。

由于研究和宣传宣传活动等活动的增加,预计该地区在预测期内仍将是最大的地区。

常问问题

Q1.市场规模有多大?

A1. 到 2030 年,全球 HbA1c 检测市场预计将达到 34 亿美元。

Q2.市场成长预测如何?

A2. 2024年至2030年,全球HbA1c检测市场预计将以12.5%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些?

A3. 此市场的主要驱动因素是糖尿病盛行率的增加和血糖控制意识的提高。

Q4.市场的主要细分市场是什么?

A4.HbA1c 检测市场的未来性充满希望,医院/诊所、诊断实验室、居家医疗和研究机构市场都有机会。

Q5.市场上主要企业有哪些?

A5.HbA1c检测的主要企业如下。

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche

Q6.未来最大的细分市场是什么?

A6.Lucintel 预测,比浊免疫检测可提供准确的结果且具有成本效益,将在预测期内达到最高的成长。

Q7. 未来五年预计哪个地区将成为最大的市场?

A7. 由于该地区研究和宣传宣传活动等活动的增加,预计北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗?

A8. 是的,Lucintel 提供 10% 的客製化服务,无需额外付费。

目录

第一章执行摘要

第二章全球 HbA1c 检测市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 市场趋势及预测分析(2018-2030)

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球 HbA1c 检测市场趋势(2018-2023)与预测(2024-2030)
  • 全球 HbA1c 测试市场:按类型
    • 装置
    • 试剂
    • 套件
  • 全球 HbA1c 测试市场:依技术分类
    • 离子交换高效液相层析法
    • 酵素测定
    • 亲和性和结合层析法
    • 比浊免疫免疫检测
    • 其他的
  • 全球 HbA1c 测试市场:依最终用途分类
    • 医院/诊所
    • 诊断实验室
    • 居家护理
    • 研究机构
    • 其他的

第四章市场趋势与预测分析:按地区(2018-2030)

  • 全球 HbA1c 测试市场:按地区
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型
    • 依技术
    • 按最终用途
    • 按地区
  • 全球 HbA1c 检测市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球 HbA1c 检测市场的容量
    • 全球 HbA1c 检测市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche
简介目录

HbA1c Testing Trends and Forecast

The future of the global HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratorie, homecare, and research institution markets. The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 12.5% from 2024 to 2030. The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.

A more than 150-page report is developed to help in your business decisions.

HbA1c Testing by Segment

The study includes a forecast for the global HbA1c testing by type, technology, end use, and region.

HbA1c Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Reagents
  • Kits

HbA1c Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Ion-Exchange HPLC
  • Enzymatic Assay
  • Affinity Binding Chromatography
  • Turbidimetric Inhibition Immunoassay
  • Others

HbA1c Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Homecare
  • Research Institution
  • Others

HbA1c Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HbA1c Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HbA1c testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HbA1c testing companies profiled in this report include-

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche

HbA1c Testing Market Insights

Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.

Within this market, hospital & clinic will remain the largest segment due to growing geriatric population.

North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.

Features of the Global HbA1c Testing Market

Market Size Estimates: HbA1c testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HbA1c testing market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: HbA1c testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the HbA1c testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HbA1c testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HbA1c testing market size?

Answer: The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030.

Q2. What is the growth forecast for HbA1c testing market?

Answer: The global HbA1c testing market is expected to grow with a CAGR of 12.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HbA1c testing market?

Answer: The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.

Q4. What are the major segments for HbA1c testing market?

Answer: The future of the HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratory, homecare, and research institution markets.

Q5. Who are the key HbA1c testing market companies?

Answer: Some of the key HbA1c testing companies are as follows.

  • Abbott
  • Bio-Rad Laboratories
  • ARKRAY
  • Danaher
  • F. Hoffmann-La Roche

Q6. Which HbA1c testing market segment will be the largest in future?

Answer: Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.

Q7. In HbA1c testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HbA1c testing market by type (instruments, reagents, and kits), technology (ion exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and others), end use (hospitals and clinics, diagnostic laboratories, homecare, research institution, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HbA1c Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HbA1c Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HbA1c Testing Market by Type
    • 3.3.1: Instruments
    • 3.3.2: Reagents
    • 3.3.3: Kits
  • 3.4: Global HbA1c Testing Market by Technology
    • 3.4.1: Ion Exchange HPLC
    • 3.4.2: Enzymatic assay
    • 3.4.3: Affinity Binding Chromatography
    • 3.4.4: Turbidimetric Inhibition Immunoassay
    • 3.4.5: Others
  • 3.5: Global HbA1c Testing Market by End Use
    • 3.5.1: Hospitals and Clinics
    • 3.5.2: Diagnostic Laboratories
    • 3.5.3: Homecare
    • 3.5.4: Research Institution
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HbA1c Testing Market by Region
  • 4.2: North American HbA1c Testing Market
    • 4.2.1: North American HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.2.2: North American HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
  • 4.3: European HbA1c Testing Market
    • 4.3.1: European HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.3.2: European HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
  • 4.4: APAC HbA1c Testing Market
    • 4.4.1: APAC HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.4.2: APAC HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
  • 4.5: ROW HbA1c Testing Market
    • 4.5.1: ROW HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
    • 4.5.2: ROW HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HbA1c Testing Market by Type
    • 6.1.2: Growth Opportunities for the Global HbA1c Testing Market by Technology
    • 6.1.3: Growth Opportunities for the Global HbA1c Testing Market by End Use
    • 6.1.4: Growth Opportunities for the Global HbA1c Testing Market by Region
  • 6.2: Emerging Trends in the Global HbA1c Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HbA1c Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HbA1c Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Bio-Rad Laboratories
  • 7.3: ARKRAY
  • 7.4: Danaher
  • 7.5: F. Hoffmann-La Roche